Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
BMC Cancer
|
April 30, 2026
De-escalation of adjuvant radio(chemo)therapy for patients with HPV-positive head and neck squamous cell carcinoma: study protocol for a phase I trial to reduce late toxicity (DELPHI)
Annett Linge, Fabian Lohaus, Steffen Appold, et al.
Clinical and Translational Radiation Oncology
|
April 17, 2018
Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
Annett Linge, Steffen Löck, Constanze Krenn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 3, 2008
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Charles Gillham, Daniel Zips, Falk Pönisch, et al.
Trials
|
November 17, 2016
PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
Sebastian Zschaeck, Monique Simon, Steffen Löck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2013
Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis
Matthias Guckenberger, Michael Allgäuer, Steffen Appold, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 24, 2015
Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure
Sebastian Zschaeck, Robert Haase, Nasreddin Abolmaali, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 23, 2017
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy
Sebastian Zschaeck, Steffen Löck, Stefan Leger, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 14, 2014
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer
Rainer J Klement, Michael Allgäuer, Steffen Appold, et al.
Clinical and Translational Radiation Oncology
|
March 6, 2019
Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
Anna Bandurska-Luque, Steffen Löck, Robert Haase, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 9, 2018
FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients
Anna Bandurska-Luque, Steffen Löck, Robert Haase, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
BMC Cancer
|
April 30, 2026
De-escalation of adjuvant radio(chemo)therapy for patients with HPV-positive head and neck squamous cell carcinoma: study protocol for a phase I trial to reduce late toxicity (DELPHI)
Annett Linge, Fabian Lohaus, Steffen Appold, et al.
Clinical and Translational Radiation Oncology
|
April 17, 2018
Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
Annett Linge, Steffen Löck, Constanze Krenn, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 3, 2008
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Charles Gillham, Daniel Zips, Falk Pönisch, et al.
Trials
|
November 17, 2016
PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial
Sebastian Zschaeck, Monique Simon, Steffen Löck, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 3, 2013
Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis
Matthias Guckenberger, Michael Allgäuer, Steffen Appold, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 24, 2015
Spatial distribution of FMISO in head and neck squamous cell carcinomas during radio-chemotherapy and its correlation to pattern of failure
Sebastian Zschaeck, Robert Haase, Nasreddin Abolmaali, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 23, 2017
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy
Sebastian Zschaeck, Steffen Löck, Stefan Leger, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 14, 2014
Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer
Rainer J Klement, Michael Allgäuer, Steffen Appold, et al.
Clinical and Translational Radiation Oncology
|
March 6, 2019
Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
Anna Bandurska-Luque, Steffen Löck, Robert Haase, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 9, 2018
FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients
Anna Bandurska-Luque, Steffen Löck, Robert Haase, et al.
Page
of 4